Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2016 December;41(4) > Minerva Endocrinologica 2016 December;41(4):421-32

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

REVIEWS  DIABETES MELLITUS AND CARDIOVASCULAR DISEASE: STRATEGIES FOR PREVENTIONFREEfree


Minerva Endocrinologica 2016 December;41(4):421-32

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Gestational diabetes mellitus diagnosis and treatment goals: measurement and measures

Polina POPOVA 1, 2, Kristin CASTORINO 3, Elena GRINEVA 1, 2, David KERR 3

1 Institution of Endocrinology, Almazov Federal North-West Medical Research Centre, Saint-Petersburg, Russia; 2 Department of Internal Diseases and Endocrinology, St Petersburg Pavlov State Medical University, St Petersburg, Russia; 3 William Sansum Diabetes Center, Santa Barbara, CA, USA


FULL TEXT  


Gestational diabetes mellitus (GDM) is defined as diabetes diagnosed during pregnancy that is not clearly overt diabetes. It is the most common complication of pregnancy and is the most common type of diabetes during pregnancy. Its high prevalence is determined by the increasing epidemic of obesity and by the diagnostic criteria applied. New criteria are currently accepted by a number of professional societies, but considerable controversies still exist concerning diagnosis of GDM. GDM can cause significant short term and long term problems for mother and offspring, including but not limited to cesarean delivery, birth trauma, as well as the development of type 2 diabetes in mother and offspring in the future. Although the consequences of poorly controlled GDM are evident, there continues to be controversy regarding the most appropriate diagnostic criteria, the metabolic aims in controlling GDM, the ability to diagnose GDM in early pregnancy, and the efficiency of treatment in order to improve pregnancy outcomes. This review focuses on current recommendations of professional medical societies and evidence base for GDM diagnosis and glycemic goals of treatment. Available evidence for the optimal time and frequency of self-monitoring of blood glucose and the role of glycated hemoglobin in GDM are provided in this review.

top of page

Publication History

Cite this article as

Corresponding author e-mail

pvpopova@yandex.ru